ESCAT; ESMO Clinical Practice Guideline (CPG); ESMO-MCBS; oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC); targeted therapy; treatment

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up / Hendriks, L E; Kerr, K M; Menis, J; Mok, T S; Nestle, U; Passaro, A; Peters, S; Planchard, D; Smit, E F; Solomon, B J; Veronesi, G; Reck, M. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 34:4(2023), pp. 339-357. [10.1016/j.annonc.2022.12.009]

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Veronesi, G
Penultimo
;
2023-01-01

Abstract

ESCAT; ESMO Clinical Practice Guideline (CPG); ESMO-MCBS; oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC); targeted therapy; treatment
2023
ESCAT
ESMO Clinical Practice Guideline (CPG)
ESMO-MCBS
oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC)
targeted therapy
treatment
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0923753422047810-main.pdf

solo gestori archivio

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Copyright dell'editore
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/152497
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 129
  • ???jsp.display-item.citation.isi??? 102
social impact